Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

ViroPharma

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of ViroPharma's 2013 immunology sales performance.

Nabriva Therapeutics appoints chief medical officer

Nabriva Therapeutics appoints chief medical officer

Her career has seen her hold positions at Shire, ViroPharma, Pfizer, GlaxoSmithKline and Merck &Co.

Merck says drug for CMV in transplant patients hits targets

Merck says drug for CMV in transplant patients hits targets phase III testing that it acquired along with ViroPharma in 2013.

FDA grants fast track designation to Shire’s Cinryze

FDA grants fast track designation to Shire’s Cinryze At the end of 2013, Shire signed a deal with US company Viropharma for around $4.2bn which gave the company rights to Cinryze.

Pharma deals in August 2015

Pharma deals in August 2015 indication]. Interestingly, the right to make the Meritage acquisition came via the purchase of ViroPharma.

Medius Deal Watch table for February 2015

Medius Deal Watch table for February 2015 Turkey. † US. †† Financial details source - Viropharma's 2013 Consolidated Financial Statement.

1 2 3 4 5 6 7 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...
Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...